PURPOSE OF REVIEW: The diagnosis of primary ciliary dyskinesia (PCD) has relied on analysis of ciliary motility and ultrastructure; however, these tests are not readily available and have not been standardized. Consequently, the diagnosis of PCD may be delayed or missed or made incorrectly. This review outlines the potential utility of new diagnostic tests, including measurement of nasal nitric oxide production and systematic analysis for mutations in genes encoding ciliary proteins. RECENT FINDINGS: Clinical manifestations of PCD have been expanded to include neonatal respiratory distress and heterotaxy. Measurement of nasal nitric oxide has emerged as a useful screening test for PCD based on the very low levels in PCD (approximately 1/10 of normal values). Genetic testing is emerging for PCD and demonstrates extensive genetic heterogeneity. Some genes and gene mutations involved in PCD have been defined. Approximately one-third of PCD cases have identifiable gene mutations in one of six different genes. An international effort is focused on defining PCD-causing defects in other genes. SUMMARY: The incorporation of nasal nitric oxide measurement as a screening test to define probable PCD cases and gene mutation analysis to make a definitive diagnosis of PCD should enhance diagnostic evaluation of PCD.
PURPOSE OF REVIEW: The diagnosis of primary ciliary dyskinesia (PCD) has relied on analysis of ciliary motility and ultrastructure; however, these tests are not readily available and have not been standardized. Consequently, the diagnosis of PCD may be delayed or missed or made incorrectly. This review outlines the potential utility of new diagnostic tests, including measurement of nasal nitric oxide production and systematic analysis for mutations in genes encoding ciliary proteins. RECENT FINDINGS: Clinical manifestations of PCD have been expanded to include neonatal respiratory distress and heterotaxy. Measurement of nasal nitric oxide has emerged as a useful screening test for PCD based on the very low levels in PCD (approximately 1/10 of normal values). Genetic testing is emerging for PCD and demonstrates extensive genetic heterogeneity. Some genes and gene mutations involved in PCD have been defined. Approximately one-third of PCD cases have identifiable gene mutations in one of six different genes. An international effort is focused on defining PCD-causing defects in other genes. SUMMARY: The incorporation of nasal nitric oxide measurement as a screening test to define probable PCD cases and gene mutation analysis to make a definitive diagnosis of PCD should enhance diagnostic evaluation of PCD.
Authors: M Zariwala; P G Noone; A Sannuti; S Minnix; Z Zhou; M W Leigh; M Hazucha; J L Carson; M R Knowles Journal: Am J Respir Cell Mol Biol Date: 2001-11 Impact factor: 6.914
Authors: C Guichard; M C Harricane; J J Lafitte; P Godard; M Zaegel; V Tack; G Lalau; P Bouvagnet Journal: Am J Hum Genet Date: 2001-02-23 Impact factor: 11.025
Authors: G Pennarun; E Escudier; C Chapelin; A M Bridoux; V Cacheux; G Roger; A Clément; M Goossens; S Amselem; B Duriez Journal: Am J Hum Genet Date: 1999-12 Impact factor: 11.025
Authors: Heike Olbrich; Karsten Häffner; Andreas Kispert; Alexander Völkel; Andreas Volz; Gürsel Sasmaz; Richard Reinhardt; Steffen Hennig; Hans Lehrach; Nikolaus Konietzko; Maimoona Zariwala; Peadar G Noone; Michael Knowles; Hannah M Mitchison; Maggie Meeks; Eddie M K Chung; Friedhelm Hildebrandt; Ralf Sudbrak; Heymut Omran Journal: Nat Genet Date: 2002-01-14 Impact factor: 38.330
Authors: Richard J B Francis; Adam Christopher; William A Devine; Lawrence Ostrowski; Cecilia Lo Journal: Am J Physiol Heart Circ Physiol Date: 2012-03-09 Impact factor: 4.733
Authors: J Tod Olin; Kim Burns; Johnny L Carson; Hilda Metjian; Jeffrey J Atkinson; Stephanie D Davis; Sharon D Dell; Thomas W Ferkol; Carlos E Milla; Kenneth N Olivier; Margaret Rosenfeld; Brock Baker; Margaret W Leigh; Michael R Knowles; Scott D Sagel Journal: Pediatr Pulmonol Date: 2011-01-31
Authors: Margaret W Leigh; Milan J Hazucha; Kunal K Chawla; Brock R Baker; Adam J Shapiro; David E Brown; Lisa M Lavange; Bethany J Horton; Bahjat Qaqish; Johnny L Carson; Stephanie D Davis; Sharon D Dell; Thomas W Ferkol; Jeffrey J Atkinson; Kenneth N Olivier; Scott D Sagel; Margaret Rosenfeld; Carlos Milla; Hye-Seung Lee; Jeffrey Krischer; Maimoona A Zariwala; Michael R Knowles Journal: Ann Am Thorac Soc Date: 2013-12
Authors: Jacelyn E Peabody; Ren-Jay Shei; Brent M Bermingham; Scott E Phillips; Brett Turner; Steven M Rowe; George M Solomon Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-03-01 Impact factor: 5.464
Authors: Ozanna Burnicka-Turek; Jeffrey D Steimle; Wenhui Huang; Lindsay Felker; Anna Kamp; Junghun Kweon; Michael Peterson; Roger H Reeves; Cheryl L Maslen; Peter J Gruber; Xinan H Yang; Jay Shendure; Ivan P Moskowitz Journal: Hum Mol Genet Date: 2016-06-23 Impact factor: 6.150